Biotechnology at University of Delaware

The estimated debt load of $20,400 for a biotechnology bachelor's degree aligns closely with what similar programs carry nationally, but the first-year earnings picture—around $47,000 based on peer programs—sits squarely at the national median for this field. That 0.43 debt-to-earnings ratio falls within reasonable territory, meaning graduates from comparable programs typically earn enough in their first year to manage their debt obligations without undue strain.

What's less clear is where University of Delaware's biotechnology program specifically positions its graduates within the broader biotech job market. Delaware's small pharma and life sciences sector means many graduates likely need to look to neighboring states like Pennsylvania, New Jersey, or Maryland for opportunities. The program's moderate selectivity (65% admission rate, 1297 average SAT) suggests solid academic preparation, but without school-specific outcomes data, you're relying on the assumption that this program performs similarly to the national middle tier.

The practical challenge: biotechnology careers often require graduate degrees or specialized certifications to reach higher earning potential, so that $47,000 first-year figure may represent just the starting point of a longer educational investment. If your child plans to enter the workforce immediately after graduation, these peer-program earnings suggest a manageable but modest financial return. If graduate school is likely, factor in additional years of education and potential debt before meaningful biotech earnings materialize.